• TARIS Biomedical Announces $25M Series B Financing biospace
    December 22, 2017
    TARIS Biomedical, a company developing targeted new therapies for millions of patients suffering from difficult-to-treat bladder diseases, announced today that it has raised $25M in a Series B financing
PharmaSources Customer Service